Liver Disease Clinical Trials

Showing 961-980 of 1,279 trials

Using the Non Invasive Technology Magnetic Resonance Elastography for the Diagnosis of Liver Fibrosis Stage

NCT03487159

This study evaluates the ability of Magnetic Resonance Elastography non invasive technology to identify the liver fibrosis stage in patients with chronic liver diseases compared to Shear Wave Elastography and/or Liver Biopsy.

Liver Diseases

Prof. Ziv Ben-Ari MD140 participantsStarted May 2018

Ramat Gan, Israel

COMPLETEDPhase 4

Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding

NCT00966355

This study is performed to compare the efficacy of terlipressin, somatostatin, and octreotide in patients with variceal bleeding for the control of variceal bleeding in combination with endoscopic therapy.

Variceal Bleeding, Cirrhosis

Korea University1,034 participantsStarted Sep 2006

Seoul, South Korea

WITHDRAWNNA

Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis

NCT03236090

Study Design: Double-blind randomized placebo-controlled clinical trial Study Duration: 2 years Study Center: Single center Hospital de la Santa Creu i Sant Pau, Barcelona Objectives: To assess the effect of Vivomixx® on neuroinflammation and systemic inflammatory response in patients with cirrhosis

Cirrhosis, Liver

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauStarted Jul 2017

Barcelona, Spain

UNKNOWNPhase 1/2

Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis

NCT03460223

In progressive kidney diseases, fibrosis represents the common pathway to end-stage kidney failure. The potential for stem cells to treat kidney failure was recently confirmed. Particularly, mesenchymal stem cell (MSC) has been demonstrated to protect kidney function and alleviating renal injury in these patients. Therefore, the investigators propose a hypothesis that MSCs (MSC) can also improve the disease conditions of kidney fibrosis patients, particularly reducing the decompensated conditions in these patients.

Renal Cirrhosis

Nanjing Medical University30 participantsStarted Apr 2018

Using the Non Invasive Technology Magnetic Resonance Elastography for the Diagnosis of Liver Fibrosis Stage

Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding

Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis

Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis

Related Searches

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Olive Oil and Soybean 1 Oil Based Intravenous Lipid Emulsions, Liver Chemistry and Clinical Outcomes

Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Marginal Graft

Applicability of 3D Printing and 3D Digital Image Reconstruction in the Planning of Complex Liver Surgery (LIV3DPRINT).

Half-life of Plasma Phytosterols in Very Low Birth Weight Preterm Infants With Parenteral Nutrition-associated Cholestasis

"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population

Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures

Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients

Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Vitamin D Level and Risk of Infections in Cirrhotic Patients

Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis

Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis

Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD

Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects

Genetics of Fatty Liver Disease in Children

Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis